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Abstract 
Background: As coronary perforation (CP) is a rare but serious complication of percutaneous 
coronary intervention (PCI) the current evidence base is limited to small series. Using a national 
PCI database the incidence, predictors and outcomes of CP as a complication of PCI were defined. 
Methods and Results: Data were prospectively collected and retrospectively analysed from the 
British Cardiovascular Intervention Society dataset on all PCI procedures performed in England and 
Wales between 2006 and 2013. Multivariable logistic regressions and propensity scores were used 
to identify predictors of CP and its association with outcomes. In total 1,762 coronary perforations 
were recorded from 527,121 PCI procedures (incidence of 0.33%). Patients with CP were more 
often female or older, with a greater burden of co-morbidity and underwent more complex PCI 
procedures. Factors  predictive of CP included age per year (odds ratio (OR) 1.03, 95% CI 1.02-
1.03, p<0.001), previous CABG (OR 1.44, 1.17-1.77, p<0.001), left main (OR 1.54, 1.21-1.96, 
p<0.001) use of rotational atherectomy (OR 2.37, 1.80-3.11, p<0.001) and CTO intervention (OR 
3.96, 3.28-4.78, p<0.001). Adjusted odds of adverse outcomes were higher for all major adverse 
coronary events including stroke, bleeding and mortality. Emergency surgery was required in 3% 
of cases. Predictors of mortality in patients with CP included age, diabetes, previous myocardial 
infarction, renal disease, ventilatory support, use of circulatory support, glycoprotein inhibitor use 
and stent type. Conclusions: Using a national PCI database for the first time the incidence, 
predictors and outcomes of coronary perforation were defined. Although CP as a complication of 
PCI occurred rarely, it was strongly associated with poor outcomes.  
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Introduction 
Coronary perforation is a rare but serious complication of percutaneous coronary intervention 
(PCI) with an estimated incidence of ~0.5%.1 Entry of arterial blood into the pericardial space can 
lead to rapid elevation of the pericardial pressure and rapid haemodynamic compromise. 
Historically urgent surgical drainage was standard treatment but the development of new 
technologies such as covered stents and embolization coils, and new techniques such as thrombus 
and fat injection have allowed many perforations to be treated in the catheterisation laboratory 
without the need for surgical intervention.2,3 However, despite improvements in interventional 
skills and equipment, percutaneous coronary interventions  are increasingly complex with a higher 
prevalence of multi-vessel disease, worsening comorbidities (such as increasing age and renal 
dysfunction) and increasingly complex procedures including treatment of chronic total occlusions 
(CTO). In light of these temporal changes it is likely that coronary perforations will continue to 
occur. 
 
Although there are several published series of coronary perforation, the rarity of the complication 
has limited the literature to small series derived from single centre experience. The largest 
published series describes 124 events and the total literature is less than 1000 cases.4-20 Given the 
small numbers of events per published series it has not been possible to examine several key 
questions relating to the occurrence and outcomes of coronary perforation. Firstly, it is unclear 
from the available evidence what the true incidence of coronary perforation is and whether its 
incidence increasing or decreasing. Secondly, because the size of the published series it is not 
been possible to define exactly which demographic and procedural factors are predictive of 
coronary perforation. Finally, the treatment and outcomes of coronary perforation are not clearly 
defined.  
 
Therefore, the objectives of the present study were to overcome these limitations and use for the 
first time a national PCI database to define the true incidence of coronary perforation during PCI, 
to describe which factors are predictive of coronary perforation, and to define the outcomes after 
coronary perforation. 
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Methods 
Study design, setting and participants 
We retrospectively analysed prospectively collected national data from all patients who underwent 
percutaneous coronary intervention (PCI) in England and Wales between January 2006 and 
December 2013. 
 
Setting, data source, and study size 
Data on PCI practice in the United Kingdom were obtained from the British Cardiovascular 
Intervention Society (BCIS) dataset that records this information prospectively and publishes this 
information in the public domain as part of the national transparency agenda.21 The overall data 
collection process is overseen by The National Institute of Cardiovascular Outcomes Research 
(NICOR) (http://www.ucl.ac.uk/nicor/) and in 2013, 98.6% of all PCI procedures performed in the 
National Health Service (NHS) hospitals in England and Wales (www.bcis.org.uk/) were recorded 
on the database. The BCIS-NICOR database contains 113 clinical, procedural and outcomes 
variables with approximately 80,000 new records added each year.22-23 The participants of the 
database are tracked by the Medical Research Information Services for subsequent mortality using 
the patients' NHS number (a unique identifier for any person registered within the NHS in England 
and Wales).  
 
Study definitions 
We analysed all recorded PCI procedures that were undertaken in the England and Wales between 
January 1st, 2006 and December 31st, 2013. Patients were categorised according to whether they 
sustained a coronary perforation during the PCI procedure or not. In the BCIS dataset the 
definition of coronary perforation is left to the discretion of the operators. The outcomes examined 
were in-hospital MACE (a composite of in-hospital mortality and in-hospital myocardial infarction 
or re-infarction and target vessel revascularization), 30-day mortality, 1-year mortality, 5-year 
mortality, in-hospital re-infarction, in-hospital emergency coronary artery bypass graft (CABG), in-
hospital cardiac tamponade, in-hospital stroke and in-hospital major bleeding (defined as 
gastrointestinal bleed, intra-cerebral bleed, retroperitoneal hematoma, blood or platelet 
transfusion, or an arterial access site complication requiring surgery). Participants with missing 
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information on coronary perforation, age or sex were excluded. A detailed account of the 
participant inclusion process is shown in Figure 1. 
 
Data analyses 
Statistical analysis was performed using Stata v13.1 (College Station, Texas, USA). Multiple 
imputations using the mi impute command were used to reduce the potential bias from missing 
data, assuming missing at random mechanisms.  We used chained equations to impute the data 
for all variables with missing information and generated 10 datasets to be used the analyses. 
 
We examined the baseline characteristics of participants by coronary perforation status. These 
variables included age, sex, smoking status, body mass index (BMI), family history of coronary 
heart disease, hypertension, hyperlipidaemia, diabetes, previous myocardial infarction, previous 
stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous 
CABG, left ventricular function, cardiogenic shock, circulatory support, mechanical ventilation, 
antiplatelet therapy, warfarin use, bivalirudin use, glycoprotein IIb/IIIa inhibitors use, vessel 
attempted for PCI (vein graft, left main, left anterior descending (LAD), circumflex, right 
coronary), post-procedural TIMI flow, radial access, stent implanted, rotational atherectomy use, 
laser angioplasty use, cutting balloon use, presence of a chronic occlusion, surgical cover, year of 
PCI, and indication (stable angina, NSTEMI, STEMI). Descriptive measures for all these variables 
were calculated over time. We tested for associations between each categorical variable and 
coronary perforation using a Chi-squared test, and for continuous variables we used one-way 
analysis of variance. In addition, the rates of coronary perforation by year of PCI are presented. 
The outcomes of interest were 30-day mortality, 1-year mortality, 5-year mortality, in-hospital 
bleeding, re-infarction, emergency CABG, stroke, cardiac tamponade, side branch occlusion and 
coronary dissection for which we initially calculated the crude rates by coronary perforation status. 
To obtain adjusted measures of the associations between coronary perforation and the outcomes, 
we used logistic regressions. In the first set of models we used multiple logistic regression and 
included all potential predictors as covariates, to quantify the independent association between 
perforation and outcomes. In a second set of models we used the potential predictors to calculate 
a propensity score on perforation and weighted simple logistic regressions, of perforation on 
outcomes, on the inverse of the score (inverse probability treatment weighting). A third set of 
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simple regressions used the propensity score to perform matching with replacement to control for 
the effect of the covariates and estimate the average treatment effect (ATE) of coronary 
perforation on outcomes (teffects psmatch in Stata).  The ATE is the mean difference in the 
outcome between patients with perforation and those without. The covariates included in the 
models were: age, gender, smoking status, body mass index, family history of coronary artery 
disease, hypercholesterolaemia, hypertension, diabetes, previous myocardial infarction, previous 
stroke, peripheral vascular disease, valvular heart disease, renal disease, previous PCI, previous 
CABG, left ventricular function, cardiogenic shock, ventilator use, circulatory support, antiplatelet 
therapy, warfarin, glycoprotein IIb/IIIa inhibitor, bivalirudin use, radial access, surgical cover, 
year, vessel of PCI, chronic occlusion, post procedure TIMI flow, stent type used, rotational 
atherectomy, laser angioplasty, cutting balloon, side branch occlusion, coronary dissection and 
diagnosis. The success of the propensity score matching was investigated by calculating 
descriptive statistics of the propensity score in each group and its absolute difference within each 
matched pair (balance diagnostics). An additional sensitivity analysis was performed by performing 
multiple logistic regressions with and without adjustments for centre volume. 
 
RESULTS 
Incidence and baseline demographics by perforation status 
Between 2006 and 2013, 1,762 coronary perforations were recorded from 527,121 PCI procedures 
giving an overall incidence of 0.33%. The crude numbers of coronary perforation increased year on 
year (Figure 2) reflecting an increase in the total PCI volume in the United Kingdom during the 
study period. However, the annual incidence varied from 0.29% to 0.36% with a trend upwards 
that did not reach statistical significance (p=0.359). The baseline demographics for patients with 
and without coronary perforation are presented in Table 1. Patients with coronary perforation were 
more often female or older, with a greater burden of co-morbidity including hypertension, 
hypercholesterolemia, previous myocardial infarction, peripheral vascular disease and left 
ventricular dysfunction. Importantly when considering consent for procedures, coronary 
perforation was more likely to occur in stable angina PCI.  
 
Procedural variables by perforation status 
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The procedural variables for patients with and without coronary perforation are presented in Table 
2. Perforation was associated with use of glycoprotein IIb/IIIa inhibitor, left main disease, 
circumflex disease, and right coronary disease, post-procedure TIMI flow, type of stent implanted, 
rotational atherectomy, laser angioplasty and chronic occlusion.  
 
Using multivariable analyses covariates found to be associated with coronary perforation were 
identified and are presented in Table 3. Factors associated with an increased risk of perforation 
were age, hypercholesterolaemia, previous CABG, left main intervention, CTO intervention, use of 
rotational atherectomy, procedural dissection, side-branch occlusion and NSTEMI diagnosis. 
Factors associated with a decreased risk of perforation were male sex, diabetes mellitus, 
presentation with shock and use of a cutting balloon.  
Clinical outcomes by perforation status 
Clinical and procedural complications and adverse outcomes recorded in the BCIS database were 
more frequent in patients with coronary perforation (Table 4). In-hospital MACE was significantly 
higher in those patients with coronary perforation compared to those without (26 vs. 2%, 
p<0.001), as was 30-day, 1-year and 5-year mortality. The 30-day mortality after perforation 
varied from 6.6% to 15.5% with a significant upward trend (P=0.049) that was also significant for 
1-year mortality (p<0.001). We observed similar significant increase in mortality at both 30-days 
and 1-year for the group that did not sustain coronary perforation over time (Supplementary Table 
1). Overall national PCI mortality with and without perforation by year is presented in Figure 3. 
The characteristics of The temporal changes in the predictive factors for perforation over time are 
presented in Supplementary Table 2 (means or percentages and respective confidence intervals) 
and indicate a significant increase in the mean complexity of the cases experiencing perforation 
(including patient age, presentation with shock, diabetes, history of CABG and left main PCI). Non-
coronary end-points including in-hospital major bleeding and stroke were also significantly more 
frequent. In patients with coronary perforation, tamponade occurred in 14% of cases with 3% of 
patients required emergency reparative surgery. Using multiple logistic regression analyses and 
inverse probability-weighting propensity scoring, the adjusted odds of clinical outcomes are 
presented in Table 5. The predictors of 30-day mortality in patients with a coronary perforation are 
presented in Table 6 and included increasing age, previous diabetes, previous myocardial 
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infarction, renal disease, use of ventilatory support, use of circulatory support, glycoprotein 
IIb/IIIa inhibitor use and stent type. The results of the propensity score matching analysis on 10 
imputed datasets using average treatment effects are demonstrated in Supplementary Table 3.  
There were significant increases in in-hospital MACE, 30-day mortality, 1-year mortality, in-
hospital cardiac tamponade and in-hospital bleeding with coronary perforation after propensity 
score matching. The balance diagnostics of the propensity score matching is are shown in 
Supplementary Table 4. In considering the effect of centre volume on outcomes the overall median 
and interquartile range of centre volume was 1,295 (617 to 1,771) procedures/year. The 
respective centre volume results for patients who had coronary perforations was lower 1,189 (599-
1,771) procedures/year. Sensitivity analysis considering the effect of an additional adjustment for 
centre volume did not significantly alter the results in the absence of this adjustment 
(Supplementary Table 5).  
 
DISCUSSION 
The current study is the first analysis of coronary perforation as a complication of percutaneous 
coronary intervention performed from a national angioplasty database. Although there are several 
previously published series, their small size has limited the robustness of any conclusions and in 
particular multiple logistic regression analyses of the predictors of coronary perforation and 
predictors of mortality in those who experience perforation have not been carried out before due 
to small sample sizes. 
 
The incidence of coronary perforation during PCI in the current study is consistent with that 
reported in the previous smaller studies and is mid-way between the lowest reported frequency of 
0.12% and the upper reported frequency of 0.82%.10,11 Two summary studies have reported on 
the occurrence of coronary perforation. The 16 published coronary perforation studies involving 
197,061 percutaneous coronary interventions were summarised recently. In this largely 
descriptive paper the perforation frequency was 0.43% although no additional analyses were 
presented.1 In the second summary analysis, Patel el al reported 419 perforations from 65 studies 
of 18,061 patients undergoing CTO PCI.25 In this series the reported frequency of coronary 
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perforation was 2.9% with a tamponade frequency of 0.2%. Although this is a large series of 
coronary perforation no further data was presented on the perforation subset of the main study. 
 
In the current study, a sub-analysis of the annualised data demonstrates not only a year on year 
increase in the crude numbers of perforation as the number of UK PCIs increases, but also a non-
significant trend for the percentage frequency to increase also. Given the independent predictors 
of perforation identified in this study, it is perhaps not surprising in view of the aging population 
with increasingly complex non-CTO and CTO procedures that the frequency of perforation is 
unlikely to drop.26-28 Based on the current data it would seem reasonable to predict that the 
frequency of coronary perforation might actually increase in coming years.  
 
Several previous studies have examined the baseline and procedural factors associated with 
perforation although none have had the sample size to perform multiple logistic regression 
analyses.4-20 The findings of these smaller studies have reported somewhat divergent findings 
although increasing age, use of rotational atherectomy, “complex” lesions and CTO intervention all 
feature more commonly. The current study largely confirms the tentative findings of previous 
studies confirming women and the elderly to be at risk of coronary perforation as well as those 
cases in which atherectomy devices are utilised. Novel predictors of coronary perforation in the 
current study include patients with previous CABG, left main stem intervention and a reduced 
frequency in diabetics and in cases with cutting balloon use. The observation that both BMS and 
DES use were associated with a lower likelihood of perforation may be explained by several factors 
including guide-wire perforation, and the fact that use of covered stent is not recorded as a 
separate field in the database. Additionally, the occurrence of a perforation with pre-dilation may 
lead operators to terminate the procedure after control of the perforation, without continuing to 
stent implantation. The observation that use of a cutting balloon appeared to be protective against 
perforation is a novel finding and may support the hypothesis that careful lesion preparation thus 
necessitating less aggressive post-dilatation could reduce the incidence of perforation. The multi-
centre nature of the database also allowed an analysis of the influence of on-site vs. off-site 
cardiac surgical support and no relationship was observed. 
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The incidence of major adverse events in patients with coronary perforation was high with a 13-
fold increase in in-hospital MACE and a 5-fold increase in 30-day mortality. These data are a stark 
reminder that whilst coronary perforation during PCI is a relatively rare event, when it does occur 
the outcome remains extremely poor. Additionally, we observed a significant increase in mortality 
at 30-days and 1-year in patients who had coronary perforation as well as patients who did not 
have coronary perforation.  This may reflect an increase in undertaking PCI on higher risk patients 
with time. However, the magnitude of increase in mortality was higher in the coronary perforation 
group compared to the non-perforation group that may also reflect the increased complexity of 
patients experiencing a perforation. Tamponade occurred in 14% of patients with coronary 
perforation, a finding that is testament to the skill of the operators necessitating rapid 
resuscitation, balloon occlusion and placement of a pericardial drain to avoid its occurrence. The 
rate of surgical repair was also extremely low (3%) in the current series and likely reflects the 
development of interventional tools such as covered stents and embolisation coils, as well as a 
wider appreciation of techniques such as distal fat and thrombus embolisation to treat distal wire 
tip perforations.2,3 The size of the current analysis also enabled a multiple logistic regression 
analysis of the predictors of an adverse outcome in those patients who experienced a coronary 
perforation. The results are largely intuitive with increasing age, previous myocardial infarction 
and renal disease all strongly predictive of increased mortality. The observed increased mortality 
associated with stent use may be explained by the lack of a dedicated covered stent field in the 
database ie use of a covered stent may be been recorded as no stent used. This analysis also 
supports the anecdotal experience that if a coronary perforation does occur, concomitant peri-
procedural use of a glycoprotein IIb/IIIa inhibitor is associated with worse outcomes, with an 
almost doubling of 30-day mortality.  
 
This analysis has several strengths. The BCIS dataset includes >98% of all PCI procedures 
performed in the UK which therefore reflects a national, real-world experience that includes high-
risk patients encountered in daily interventional practice (who are often excluded from randomized 
controlled trials). Therefore, for the first time the occurrence of perforation is reported on a 
national basis. Our analysis of over ½ million PCI procedures represents that largest analysis to 
date by several orders of magnitude, analysing temporal trends, predictors and outcomes for the 
first time derived from over 1700 perforations. Such large national registry data with unselected 
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enrolment are important for evaluation of low frequency complications such as coronary 
perforation, particularly given that such low event rates would mean that single centre 
registries/RCTs would be grossly underpowered. 
 
LIMITATIONS 
Additionally although the BCIS database does not specifically define perforation (leaving recording 
of this complication at the discretion of the operator), the observed incidence of perforation in our 
large series implies that reasonable clinical judgment was applied by UK operators. Secondly, 
whilst the BCIS dataset provides granular information about clinical and procedural characteristics, 
it does not provide information around vessel and lesion characteristics such as tortuosity, 
calcification, side branch proximity and lesion diameter and length. Additionally, the BCIS 
database does not differentiate between coronary perforations resulting from guide-wire and 
perforations due to vessel rupture by balloon or stent inflation. Therefore, we are unable to 
provide separate analyses regarding the predictors and outcomes of these sub-groups of coronary 
perforation. Additionally, the definition of perforation was not standardized and the database does 
not record the Ellis classification of coronary perforation. A sub-stratification by perforation 
severity is not possible within the constraints of the current dataset. The independent associations 
between covariates and a perforation complication that we have reported cannot infer causality, 
but may relate to changes in the procedure/clinical status occurring as a consequence of the 
perforation. For example, the use of circulatory support is associated with increased odds of 
perforation 4-fold, but this may not be a causal but merely reflect that post perforation, patients 
are more likely to require circulatory support because of significant haemodynamic compromise. 
Similarly side-branch occlusion may be associated with use of a covered stent. Finally, the BCIS 
database only records emergency CABG as an outcome after coronary perforation. As a result, we 
are unable to provide data on the use of covered stents, pericardial drains or embolisation coils. 
Finally, census data was only available at specific time points with follow-times to census weredata 
not available in the database extract that was used for this we obtained and hence our analysis 
options were limited to logistic regression models. IHowever, it has, however been shown that for 
relatively short follow-up times (up to 5 years) the performance of logistic regression models is not 
too dissimilar to survival analysis models. 
Comment [EK1]: http://onlinelibrar
y.wiley.com/doi/10.1002/sim.478008
1211/abstract 
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CONCLUSIONS 
Using data derived from a national PCI database, coronary perforation occurred as a PCI 
procedural complication in 0.33% of cases. Independent predictors of coronary perforation 
included age, female gender, chronic total occlusion intervention and atherectomy. Coronary 
perforation was strongly associated with poor outcomes.  
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